🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Weeeee!!! We we're hiring 2 PhD-level research scientists in the Kevin Esvelt Sculpting Evolution lab! If you're interested in mammalian bioeng, evolution & solving big problems please apply and share!! Mammalian bioeng: bit.ly/3AbpLD7 Biotech: bit.ly/3yiF1xk

All catastrophic bio-threats grow exponentially All bio is made of nucleic acids To detect all threats, deep sequence wastewater + rivers & look for exponentially growing fragments (k-mers) arxiv.org/abs/2108.02678 #NAO 2/20

To credibly identify a virus as capable of causing a pandemic – of inflicting more casualties than any nuclear warhead – is to give thousands the power to wield it as a weapon. Let's not. #PandemicNonproliferation washingtonpost.com/opinions/2021/…

Interesting paper by D Smith & D Montefiori groups (& others) on how antibodies elicited by primary infection w one #SARSCoV2 variant neutralize other variants: biorxiv.org/content/10.110… Informative for thinking about how exposure to one variant might protect against another (1/n)

I wrote for Vox about viral discovery, going out into nature to find lots of viruses and maybe find one that'll cause a future pandemic: vox.com/future-perfect…. When I first started writing about pandemics, I was pretty excited about viral discovery work.

This is quite clever, gotta say: biorxiv.org/content/10.110… mRNA vaccines to generate Spike eVLPs which show significantly better neutralization than current mRNA vaccines (or at least an analog of them) do preclinically and superior T cell responses.

Highly rec Jim Collins' "Good to Great" book series (there's 6 of them total) for anyone involved in trying to build an org. Incredibly sticky concepts for what differentiates great vs mediocre orgs, fantastically communicated, based on case studies. Really changed my perspective

Excited to see announcement of the DARPA HERMES program to develop new modalities for delivery of biologics: darpa.mil/news-events/20… Especially eager to see advances in lung delivery, which would open up whole new prevention/tx strategies for respiratory infections!

Realizing I could access Kindle books on my phone changed everything

Happy to have contributed to the new Asimov Press pandemic prevention mini-issue! How can "Day Zero antivirals" complement vaccines? Find out in the article - and also find out what we've been up to Panoplia Laboratories

My very first ever podcast appearance! Check out the latest You Make Me Sick! Podcast episode to hear about Day Zero broad-spectrum antivirals and the work we're doing at Panoplia Laboratories. Listen until the very end for a silly surprise :)

💡The first release of our far-UVC Blueprint is here💡 Two years in the making, the report contains a highly comprehensive overview of this promising technology for combatting airborne disease More than just a resource though, it's a plan for advancing the far-UVC field. 🔗⤵️

Far UVC can cut airborne bacteria by 98.4 percent, and could do the same for viruses, preventing diseases spread in public spaces. But it is held back because it is unpatentable, which means it is unproven, unregulated, and untrusted. We can fix this. worksinprogress.news/p/flipping-the…

Incredibly excited to share this news: I’m joining ARIA as a new Programme Director! If you’re in the UK R&D ecosystem and the phrase “sculpting innate immunity for better health” resonates with you, please don’t hesitate to reach out—I want to hear from you!

Really cool comprehensive mapping of gaps in R&D by Convergent Research: gap-map.org (minor contributions by me pre-ARIA) Would love to hear if you're working on anything in the biosecurity, immunology, and physiology + medicine sections in particular - reach out!

Excited to announce my opportunity space at ARIA - Sculpting Innate Immunity! Take a look to see why I think fine-tuning the innate branch of the immune system can be transformative for health – and why we now have the tools to do so.

v1 of our ARIA opportunity space 'Trust Everything, Everywhere' is now live! we're focusing on new security primitives that straddle digital and physical worlds, and will be spending the next months zeroing in on a £10-100m first challenge within the space 🎯